COPD Treatment Market: Current Analysis and Forecast (2022-2030)
Emphasis on Type (Chronic bronchitis, Emphysema); Drug Class (Bronchodilators, Corticosteroids, Combination drugs, Roflumilast (phosphodiesterase-4 inhibitor), Others); Distribution Channel (Hospital Pharmacies, Retails Pharmacies, Online Pharmacies); and Region/Country
The COPD treatment market was valued at USD 17.3 billion in 2022 & is expected to grow at a CAGR of 5.3% from 2023-2030. Chronic obstructive pulmonary disease (COPD) is a group of diseases that cause airway obstruction and breathing problems. These include emphysema and chronic bronchitis. The rising prevalence of COPD, primarily due to factors like smoking, air pollution, and ageing populations, is the driving factor for the market growth of the COPD treatment market. For Instance, according to the WHO, in 2023, Chronic obstructive pulmonary disease (COPD) is the third leading cause of death worldwide. Nearly 90% of COPD deaths in those under 70 years of age occur in low- and middle-income countries (LMIC). Furthermore, the COPD treatment market has witnessed advancements in therapies, medications, and devices that aim to manage symptoms, improve lung function, and enhance the quality of life for COPD patients. The availability of new treatment options encourages the growth of the market. For instance, in 2022, GlaxoSmithKline Pharmaceuticals Limited launched Trelegy Ellipta (fluticasone furoate/umeclidinium/vilanterol), the first single-inhaler triple therapy (SITT) in India for Chronic Obstructive Pulmonary Disease (COPD) patients in a once-daily regime.
Some of the major players operating in the market GSK plc, Cipla Inc., Boehringer Ingelheim, Verona Pharma plc, Circassia Group PLC, Pfizer Inc, Sanofi, Almirall, S.A, Teva Pharmaceutical Industries Ltd., Astellas Pharma Inc. Several M&As along with partnerships have been undertaken by these players to facilitate customers with hi-tech and innovative products/technologies.
Insights Presented in the Report
“Amongst type, the chronic bronchitis segment held a significant share of the market in 2022.”
Based on the type, the market has been categorized into chronic bronchitis and emphysema. Among them, the chronic bronchitis segment is expected to grow at the highest CAGR in the market. Chronic bronchitis is a group of lung diseases that causes airflow blockages and breathing issues. It is widespread among smokers and rising at a rapid pace. The prevalence of chronic bronchitis is increasing worldwide, especially among the elderly.
“Amongst drug class, the combination drugs segment held the higher CAGR in the market in 2022.”
Based on the drug class, the market has been categorized into bronchodilators, corticosteroids, combination drugs, roflumilast (phosphodiesterase-4 inhibitor), and others. Among them, the combination drugs segment is expected to grow at a higher CAGR in the market. Combination therapy uses multiple drugs, such as bronchodilators and corticosteroids, to relieve symptoms of COPD and improve lung function.
“North America dominated the COPD treatment market in 2021.”
The North America COPD treatment market is expected to grow in the coming years, driven by the increasing prevalence of COPD and growing awareness of COPD among healthcare professionals and the general population, the increasing smoking cessation efforts and the rise in air pollution levels. For instance, according to the American Lung Association, in the United States, In 2020, 12.5 million people, or 5.0% of adults, reported a diagnosis of COPD (chronic obstructive pulmonary disease, chronic bronchitis, or emphysema.
COPD Treatment Market Report Coverage
Reasons to buy this report:
- The study includes market sizing and forecasting analysis validated by authenticated key industry experts.
- The report presents a quick review of overall industry performance at one glance.
- The report covers an in-depth analysis of prominent industry peers with a primary focus on key business financials, product portfolios, expansion strategies, and recent developments.
- Detailed examination of drivers, restraints, key trends, and opportunities prevailing in the industry.
- The study comprehensively covers the market across different segments.
- Deep dive regional level analysis of the industry.
Customization Options:
The global COPD treatment market can further be customized as per the requirement or any other market segment. Besides this, UMI understands that you may have your own business needs, hence feel free to connect with us to get a report that completely suits your requirements.
Table of Contents
Research Methodology for the COPD Treatment Market Analysis (2023-2030)
Analyzing the historical market, estimating the current market, and forecasting the future market of the global COPD treatment market were the three major steps undertaken to create and analyze the adoption of COPD treatment in major regions globally. Exhaustive secondary research was conducted to collect the historical market numbers and estimate the current market size. Secondly, to validate these insights, numerous findings and assumptions were taken into consideration. Moreover, exhaustive primary interviews were also conducted, with industry experts across the value chain of the global COPD treatment market. Post assumption and validation of market numbers through primary interviews, we employed a top-down/bottom-up approach to forecasting the complete market size. Thereafter, market breakdown and data triangulation methods were adopted to estimate and analyze the market size of segments and sub-segments of the industry pertains to. Detailed methodology is explained below:
Analysis of Historical Market Size
Step 1: In-Depth Study of Secondary Sources:
Detail secondary study was conducted to obtain the historical market size of the COPD treatment market through company internal sources such as annual reports & financial statements, performance presentations, press releases, etc., and external sources including journals, news & articles, government publications, competitor publications, sector reports, third-party database, and other credible publications.
Step 2: Market Segmentation:
After obtaining the historical market size of the COPD treatment market, we conducted a detailed secondary analysis to gather historical market insights and share for different segments & sub-segments for major regions. Major segments are included in the report as type, drug class, and distribution channel. Further country-level analyses were conducted to evaluate the overall adoption of testing models in that region.
Step 3: Factor Analysis:
After acquiring the historical market size of different segments and sub-segments, we conducted a detailed factor analysis to estimate the current market size of the COPD treatment market. Further, we conducted factor analysis using dependent and independent variables such as type, drug class, and distribution channel of the COPD treatment market. A thorough analysis was conducted for demand and supply-side scenarios considering top partnerships, mergers and acquisitions, business expansion, and product launches in the COPD treatment market sector across the globe.
Current Market Size Estimate & Forecast
Current Market Sizing: Based on actionable insights from the above 3 steps, we arrived at the current market size, key players in the global COPD treatment market, and market shares of the segments. All the required percentage shares split, and market breakdowns were determined using the above-mentioned secondary approach and were verified through primary interviews.
Estimation & Forecasting: For market estimation and forecast, weights were assigned to different factors including drivers & trends, restraints, and opportunities available for the stakeholders. After analyzing these factors, relevant forecasting techniques i.e., the top-down/bottom-up approach were applied to arrive at the market forecast for 2030 for different segments and sub-segments across the major markets globally. The research methodology adopted to estimate the market size encompasses:
- The industry’s market size, in terms of revenue (USD) and the adoption rate of the COPD treatment market across the major markets domestically
- All percentage shares, splits, and breakdowns of market segments and sub-segments
- Key players in the global COPD treatment market in terms of products offered. Also, the growth strategies adopted by these players to compete in the fast-growing market
Market Size and Share Validation
Primary Research: In-depth interviews were conducted with the Key Opinion Leaders (KOLs) including Top Level Executives (CXO/VPs, Sales Head, Marketing Head, Operational Head, Regional Head, Country Head, etc.) across major regions. Primary research findings were then summarized, and statistical analysis was performed to prove the stated hypothesis. Inputs from primary research were consolidated with secondary findings, hence turning information into actionable insights.
Split of Primary Participants in Different Regions
Market Engineering
The data triangulation technique was employed to complete the overall market estimation and to arrive at precise statistical numbers for each segment and sub-segment of the global COPD treatment market. data was split into several segments & sub-segments post studying various parameters and trends in the areas of the type, drug class, and distribution channel in the global COPD treatment market.
The main objective of the Global COPD treatment Market Study
The current & future market trends of the global COPD treatment market were pinpointed in the study. Investors can gain strategic insights to base their discretion for investments on the qualitative and quantitative analysis performed in the study. Current and future market trends determined the overall attractiveness of the market at a regional level, providing a platform for the industrial participant to exploit the untapped market to benefit from a first-mover advantage. Other quantitative goals of the studies include:
- Analyze the current and forecast market size of the COPD treatment market in terms of value (USD). Also, analyze the current and forecast market size of different segments and sub-segments
- Segments in the study include areas of the type, drug class, and distribution channel
- Define and analysis of the regulatory framework for the COPD treatment industry
- Analyze the value chain involved with the presence of various intermediaries, along with analyzing customer and competitor behaviors of the industry
- Analyze the current and forecast market size of the COPD treatment market for the major region
- Major countries of regions studied in the report include Asia Pacific, Europe, North America, and the Rest of the World
- Company profiles of the COPD treatment market and the growth strategies adopted by the market players to sustain in the fast-growing market
- Deep dive regional level analysis of the industry
Related Reports
Customers who bought this item also bought
Antibiotic Resistance Market: Current Analysis and Forecast (2024-2032)
Emphasis on Disease Type (Urinary Tract Infections, Intra-Abdominal Infections, Blood Stream Infections, Clostridium Difficile Infections, And Others); Pathogen Type (Acinetobacter baumannii, Pseudomonas aeruginosa, Staphylococcus aureus, Streptococcus pneumoniae, and Others); Drug Class (Oxazolidinones, Lipoglycopeptides, Tetracyclines, and Others); and Region/Country
October 8, 2024
